Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid in morbidly obese patients before bariatric surgery
2007-005531-28Phase 2Completed
- Sponsor
- Hanns-Ulrich Marschall
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Hanns-Ulrich Marschall. Primary endpoint: Molecular characterization of hepatobiliary transporters and bile acid metabolism. Started Feb 2008; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on 2007-005531-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005531-28.